Trial Condition(s):
Magnetic Resonance Imaging, Kidney Neoplasms
MRI study of 1.0 molar Gadobutrol and 0.5 molar Gd-DTPA with a single i.v. injection in patients with known or suspected renal lesions
Bayer Identifier:
90931
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
Study Completed
Trial Purpose
Please see attached Study Results Summary below.
Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available
Trial Summary
Enrollment Goal
471
Trial Dates
Phase
3
Could I receive a placebo?
No
Products
Gadavist/Gadovist (Gadobutrol, BAY86-4875)
Accepts Healthy Volunteers
N/A
Where to Participate
Locations
Status
| Locations | Status |
|---|
Trial Design
A multicenter, single-blind, randomized, inter-individually controlled MRI study of 1.0 molar gadobutrol and 0.5 molar Gd-DTPA with a single i.v. injection in patients with known or suspected renal lesions
Trial Type:
Interventional
Intervention Type:
N/A
Trial Purpose:
N/A
Allocation:
N/A
Blinding:
N/A
Assignment:
N/A
Trial Arms:
N/A
Primary Outcome
- Timeframe:
Secondary Outcome
- Timeframe:
Additional Information
Copyright © Bayer
Powered by
